Fundz

AnHeart Therapeutics Appoints Charlotte Arnold as Chief Corporate Affairs Officer

PRIVATESep 28, 2023

Position

Chief Corporate Affairs Officer

Company

AnHeart Therapeutics

Charlotte Arnold
carnold@anhearttherapeutics.com
New YorkManufacturingBiotechnologyHealth CareScience And EngineeringTherapeuticsPharmaceuticalBiopharma

Description

NEW YORK–– AnHeart Therapeutics , a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today announced the appointment of Charlotte Arnold as Chief Corporate Affairs Officer.

Quick answer

AnHeart Therapeutics Appoints Charlotte Arnold as Chief Corporate Affairs Officer (September 28, 2023). AnHeart Therapeutics is based in New York, New York, United States.

Who is the new Chief Corporate Affairs Officer at AnHeart Therapeutics?
AnHeart Therapeutics named Charlotte Arnold Chief Corporate Affairs Officer, announced September 28, 2023.
What did AnHeart Therapeutics announce on September 28, 2023?
NEW YORK–– AnHeart Therapeutics , a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today announced the appointment of Charlotte Arnold as Chief Corporate Affairs Officer.
What does AnHeart Therapeutics do?
AnHeart Therapeutics Ltd. is a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer.
Where is AnHeart Therapeutics based?
AnHeart Therapeutics is based in New York, New York, United States.
Which similar companies made leadership changes around the same time?
Pfizer (September 28, 2023), Royalty Pharma plc (September 21, 2023), Madrigal Pharmaceuticals (September 14, 2023) and Dimerix Limited (October 23, 2023) also announced leadership changes within 45 days of AnHeart Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at AnHeart Therapeutics, and when

A new leader at AnHeart Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day AnHeart Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AnHeart Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AnHeart Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AnHeart Therapeutics

Location

New York, New York, United States

About

AnHeart Therapeutics Ltd. is a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer. Their lead asset, taletrectinib, is a next-generation ROS1 inhibitor with potentially best-in-class profile aiming to overcome the limitations of existing therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AnHeart Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Charlotte
Likely contact at this company
••••••••@••••••••

See Charlotte's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for AnHeart Therapeutics's next move

Learn about Strategic plan

AnHeart Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.